HK1022848A1 - Use of a combination of h+, k+-atpase inhibitors and glucocorticoids in the treatment of nasal polyps - Google Patents

Use of a combination of h+, k+-atpase inhibitors and glucocorticoids in the treatment of nasal polyps

Info

Publication number
HK1022848A1
HK1022848A1 HK00102015A HK00102015A HK1022848A1 HK 1022848 A1 HK1022848 A1 HK 1022848A1 HK 00102015 A HK00102015 A HK 00102015A HK 00102015 A HK00102015 A HK 00102015A HK 1022848 A1 HK1022848 A1 HK 1022848A1
Authority
HK
Hong Kong
Prior art keywords
glucocorticoids
treatment
combination
nasal polyps
atpase inhibitors
Prior art date
Application number
HK00102015A
Other languages
English (en)
Inventor
Per Lindberg
Joan Pinas-Masso
Jordi Serra-Carreras
Jan Trofast
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of HK1022848A1 publication Critical patent/HK1022848A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Otolaryngology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
HK00102015A 1996-10-11 2000-04-03 Use of a combination of h+, k+-atpase inhibitors and glucocorticoids in the treatment of nasal polyps HK1022848A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9603725A SE9603725D0 (sv) 1996-10-11 1996-10-11 New teatment
PCT/SE1997/001651 WO1998016228A1 (en) 1996-10-11 1997-10-01 USE OF AN H+, K+-ATPase INHIBITOR IN THE TREATMENT OF NASAL POLYPS

Publications (1)

Publication Number Publication Date
HK1022848A1 true HK1022848A1 (en) 2000-08-25

Family

ID=20404214

Family Applications (1)

Application Number Title Priority Date Filing Date
HK00102015A HK1022848A1 (en) 1996-10-11 2000-04-03 Use of a combination of h+, k+-atpase inhibitors and glucocorticoids in the treatment of nasal polyps

Country Status (34)

Country Link
EP (1) EP0946175B1 (ja)
JP (1) JP4100713B2 (ja)
KR (1) KR100510812B1 (ja)
CN (1) CN1146416C (ja)
AR (1) AR008886A1 (ja)
AT (1) ATE230597T1 (ja)
AU (1) AU738310B2 (ja)
BR (1) BR9711896A (ja)
CA (1) CA2268305C (ja)
CZ (1) CZ298799B6 (ja)
DE (1) DE69718347T2 (ja)
DK (1) DK0946175T3 (ja)
EE (1) EE04043B1 (ja)
ES (1) ES2188995T3 (ja)
HK (1) HK1022848A1 (ja)
HU (1) HUP0000036A3 (ja)
ID (1) ID23692A (ja)
IL (1) IL129324A0 (ja)
IS (1) IS1930B (ja)
MY (1) MY117918A (ja)
NO (1) NO321007B1 (ja)
NZ (1) NZ334786A (ja)
PL (1) PL190902B1 (ja)
PT (1) PT946175E (ja)
RS (1) RS49599B (ja)
RU (1) RU2197966C2 (ja)
SA (1) SA97180641B1 (ja)
SE (1) SE9603725D0 (ja)
SK (1) SK284252B6 (ja)
TR (1) TR199900770T2 (ja)
TW (1) TW568784B (ja)
UA (1) UA59374C2 (ja)
WO (1) WO1998016228A1 (ja)
ZA (1) ZA978842B (ja)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
US6489346B1 (en) 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
TR200100560T2 (tr) 1998-08-18 2002-05-21 The Regents Of The University Of California EGF-R Antagonistlerinin uygulanmasıyla nefes yolunda mukus üretiminin önlenmesi
US6846799B1 (en) * 1998-08-18 2005-01-25 The Regents Of The University Of California Preventing airway mucus production by administration of EGF-R antagonists
US7354894B2 (en) 1998-08-18 2008-04-08 The Regents Of The University Of California Preventing airway mucus production by administration of EGF-R antagonists
AU2002342917A1 (en) * 2001-11-19 2003-06-10 Altana Pharma Ag Reversible proton pump inhibitors for the treatment of airway disorders
PL370839A1 (en) * 2002-03-14 2005-05-30 Altana Pharma Ag Use of proton pump inhibitors for the treatment of airway disorders
CN1652822A (zh) * 2002-05-07 2005-08-10 奥坦纳医药公司 用于治疗气道病症的可逆质子泵抑制剂和气道治疗剂的新组合
WO2003094968A2 (en) * 2002-05-07 2003-11-20 Altana Pharma Ag Combination of a proton pump inhibitor and a respiratory agent for the treatment of respiratory diseases
FR2845915B1 (fr) * 2002-10-21 2006-06-23 Negma Gild Utilisation du tenatoprazole pour le traitement du reflux gastro-oesophagien
PT1572217E (pt) 2002-12-12 2008-11-28 Nycomed Gmbh Medicamento combinado de r,r-formoterol e ciclesonida
US8993599B2 (en) 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
PL1670482T5 (pl) 2003-09-16 2022-10-03 Covis Pharma Gmbh Zastosowanie cyklezonidu w leczeniu chorób układu oddechowego
US8906940B2 (en) 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
CN104408249B (zh) * 2014-11-24 2017-09-26 广州供电局有限公司 单芯电缆导体热性参数的确定方法及系统
KR101974504B1 (ko) * 2017-04-10 2019-05-03 재단법인 아산사회복지재단 호산구성 비용종 동물모델

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1429184A (en) * 1972-04-20 1976-03-24 Allen & Hanburys Ltd Physically anti-inflammatory steroids for use in aerosols
GB1571629A (en) * 1977-11-30 1980-07-16 Fisons Ltd Pharmaceutical compositions containing beclomethasone dipropionate

Also Published As

Publication number Publication date
ZA978842B (en) 1998-04-14
IS1930B (is) 2004-05-18
CN1146416C (zh) 2004-04-21
MY117918A (en) 2004-08-30
DE69718347D1 (de) 2003-02-13
RU2197966C2 (ru) 2003-02-10
UA59374C2 (uk) 2003-09-15
JP4100713B2 (ja) 2008-06-11
ES2188995T3 (es) 2003-07-01
HU0000036D0 (ja) 2002-05-29
PL190902B1 (pl) 2006-02-28
SA97180641B1 (ar) 2005-12-18
TW568784B (en) 2004-01-01
IS5021A (is) 1999-04-08
NZ334786A (en) 2000-12-22
DE69718347T2 (de) 2003-08-28
ATE230597T1 (de) 2003-01-15
EP0946175B1 (en) 2003-01-08
YU16399A (sh) 2000-03-21
WO1998016228A1 (en) 1998-04-23
NO991619L (no) 1999-04-06
EP0946175A1 (en) 1999-10-06
CA2268305A1 (en) 1998-04-23
BR9711896A (pt) 1999-08-24
IL129324A0 (en) 2000-02-17
KR20000049046A (ko) 2000-07-25
HUP0000036A2 (hu) 2002-05-29
JP2001508034A (ja) 2001-06-19
SE9603725D0 (sv) 1996-10-11
SK284252B6 (sk) 2004-12-01
ID23692A (id) 2000-05-11
AU4640997A (en) 1998-05-11
NO991619D0 (no) 1999-04-06
DK0946175T3 (da) 2003-03-17
PL332692A1 (en) 1999-09-27
EE9900118A (et) 1999-10-15
CA2268305C (en) 2006-11-28
EE04043B1 (et) 2003-06-16
KR100510812B1 (ko) 2005-08-31
CN1232397A (zh) 1999-10-20
SK38499A3 (en) 2000-03-13
NO321007B1 (no) 2006-02-27
CZ122999A3 (cs) 1999-09-15
RS49599B (sr) 2007-06-04
PT946175E (pt) 2003-04-30
TR199900770T2 (xx) 1999-06-21
AR008886A1 (es) 2000-02-23
AU738310B2 (en) 2001-09-13
HUP0000036A3 (en) 2003-02-28
CZ298799B6 (cs) 2008-02-06

Similar Documents

Publication Publication Date Title
HK1022848A1 (en) Use of a combination of h+, k+-atpase inhibitors and glucocorticoids in the treatment of nasal polyps
HUP9904361A3 (en) Use of isobutylgaba and its derivatives for the treatment of pain
EP0950025A4 (en) WATER TREATMENT AND CLEANING
EP0685219A3 (de) Haarbehandlungsmittel und Verfahren zur Anwendung.
ZA979731B (en) Treatment of asthma.
ZA975288B (en) The use of TCET in the prophylaxis and treatment of allergies.
AU5838700A (en) Method for treating and preventing finger disorders
HK1018271A1 (en) Substituted benzylamines and their use for the treatment of depression
AU5929499A (en) A wound treatment composition and a wound dressing containing it
AU2529799A (en) Benzofuran-4-carboxamides and their therapeutic use
MXPA01005600A (es) Peptidos pequenos y metodos para tratamiento de asma e inflamacion.
SI0946175T1 (en) USE OF A COMBINATION OF H+, K+ -ATPase INHIBITORS AND GLUCOCORTICOIDS IN THE TREATMENT OF NASAL POLYPS
IL120383A0 (en) Use of naphthalene derivatives in treating lung carcinoma
EP1032266A4 (en) USE OF DELTA-5-ANDROSTEN-3-BETA-OL-7,17-DION IN THE TREATMENT OF ARTHRITIS
ZA991786B (en) Therapeutic treatment for asthma.
AU3061199A (en) Skin treatment compositions and the use thereof
AU2713797A (en) Depigmentating agent in the treatment of melasma
IL127040A0 (en) Use of substituted azaspirane in the treatment of asthma
AU4402497A (en) Methods and means for the treatment of malignancies
AU7063798A (en) Water treatment and delivery apparatus
AU2001268762A1 (en) Treatment and therapy apparatus
ZA971526B (en) Quinolones and their therapeutic use.
GB9425059D0 (en) Carcinoma treatment
GB9602405D0 (en) Anti-smoking treatment, therapy and illness prevention
ZA991021B (en) Benzofuran-4-carboxamides and their therapeutic use.

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20081001